Germline BRCA-mutated metastatic breast cancer with positive hormone receptor

被引：0
|
作者：
Michela Palleschi
Maria Laura Iaia
Chiara Casadei
机构：
[1] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,
来源：
Breast Cancer Research and Treatment | 2021年 / 186卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 266
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study
    Kotani, Haruru
    Masuda, Norikazu
    Yamashita, Toshinari
    Naito, Yoichi
    Taira, Tetsuhiko
    Inoue, Kenichi
    Takahashi, Masato
    Yonemori, Kan
    Toyoizumi, Shigeyuki
    Mori, Yuko
    Nagasawa, Takashi
    Hori, Natsuki
    Iwata, Hiroji
    BREAST CANCER, 2022, 29 (06) : 1088 - 1098
  • [32] Clinical behavior and outcomes of BRCA-mutated breast cancer in young patients according to type of BRCA mutation and hormone receptor status: Results from an international cohort study
    Lambertini, Matteo
    Ceppi, Marcello
    Hamy, Anne-Sophie
    Caron, Olivier
    Poorvu, Philip D.
    Carrasco, Estela
    Grinshpun, Albert
    Punie, Kevin
    Rousset-Jablonski, Christine
    Ferrari, Alberta
    Paluch-Shimon, Shani
    Toss, Angela
    Senechal, Claire
    Puglisi, Fabio
    Pogoda, Katarzyna
    Perez-Fidalgo, Jose Alejandro
    De Marchis, Laura
    Ponzone, Riccardo
    Livraghi, Luca
    Estevez-Diz, Maria Del Pilar
    Villarreal-Garza, Cynthia
    Dieci, Maria Vittoria
    Clatot, Florian
    Duhoux, Francois P.
    Graffeo, Rossella
    Teixeira, Luis
    Cordoba, Octavi
    Sonnenblick, Amir
    Ferreira, Arlindo R.
    Partridge, Ann H.
    Di Meglio, Antonio
    Saule, Claire
    Peccatori, Fedro A.
    Bruzzone, Marco
    Del Mastro, Lucia
    Ameye, Lieveke
    Balmana, Judith
    Azim, Hatem A., Jr.
    CANCER RESEARCH, 2021, 81 (04)
  • [33] Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial
    Hurvitz, Sara A.
    Gocalves, Anthony
    Rugo, Hope S.
    Lee, Yung-Hun
    Fehrenbacher, Louis
    Mina, Lida A.
    Diab, Sami
    Blum, Joanne L.
    Chakrabarti, Jayeta
    Elmeliegy, Mohamed
    DeAnnuntis, Liza
    Gauthier, Eric
    Czibere, Akos
    Tudor, Iulia Cristina
    Quek, Ruben G. W.
    Litton, Jennifer K.
    Ettl, Johannes
    ONCOLOGIST, 2020, 25 (03): : E439 - E450
  • [34] Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy
    Cruz, Cristina
    Llop-Guevara, Alba
    Garber, Judy E.
    Arun, Banu K.
    Perez Fidalgo, Jose A.
    Lluch, Ana
    Telli, Melinda L.
    Fernandez, Cristian
    Kahatt, Carmen
    Galmarini, Carlos M.
    Soto-Matos, Arturo
    Alfaro, Vicente
    Perez de la Haza, Aitor
    Domchek, Susan M.
    Antolin, Silvia
    Vahdat, Linda
    Tung, Nadine M.
    Lopez, Rafael
    Arribas, Joaquin
    Vivancos, Ana
    Baselga, Jose
    Serra, Violeta
    Balmana, Judith
    Isakoff, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (31) : 3134 - +
  • [35] An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Updated results in patients with germline BRCA-mutated (gBRCAm) metastatic breast cancer (MBC)
    Domchek, S. M.
    Postel-Vinay, S.
    Im, S-A
    Park, Y. Hee
    Delord, J-P
    Italiano, A.
    Alexandre, J.
    You, B.
    Bastian, S.
    Krebs, M. G.
    Waqar, S.
    Lanasa, M.
    Angell, H. K.
    Tang, M.
    Gresty, C.
    Opincar, L.
    Herbolsheimer, P.
    Kaufman, B.
    CANCER RESEARCH, 2019, 79 (04)
  • [36] Everolimus in metastatic hormone-receptor positive Breast Cancer
    Richter-Ehrenstein, C.
    ONKOLOGE, 2012, 18 (05): : 435 - +
  • [37] Leptomeningeal carcinomatosis in BRCA-mutated pancreatic cancer.
    Slostad, Jessica Anne
    Hallemeier, Christopher Leigh
    Bamlet, William R.
    Couch, Fergus
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [38] Olaparib for the treatment of BRCA-mutated advanced ovarian cancer
    Munroe, Marklie
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (14) : 1037 - 1041
  • [39] Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer
    Sonderstrup, I. M. H.
    Jensen, M. B.
    Ejlertsen, B.
    Eriksen, J. O.
    Gerdes, A. M.
    Kruse, T. A.
    Larsen, M. J.
    Thomassen, M.
    Laenkholm, A. V.
    ACTA ONCOLOGICA, 2019, 58 (03) : 363 - 370
  • [40] BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
    Arun, Banu
    Couch, Fergus J.
    Abraham, Jean
    Tung, Nadine
    Fasching, Peter A.
    BRITISH JOURNAL OF CANCER, 2024, 131 (09) : 1400 - 1414
12345